Corrigendum to "Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1362 patients" [Int. J. Cardiol. 203 (Nov. 24 2015) 906–908]. (15th April 2016)